APA (7th ed.) Citation

P, R., SD, A., G, F., B, P., LM, R., AL, B., . . . R, A. (2022). Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes care, 45(12), 2991. https://doi.org/10.2337/dc22-0294

Chicago Style (17th ed.) Citation

P, Rossing, et al. "Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis." Diabetes Care 45, no. 12 (2022): 2991. https://doi.org/10.2337/dc22-0294.

MLA (9th ed.) Citation

P, Rossing, et al. "Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis." Diabetes Care, vol. 45, no. 12, 2022, p. 2991, https://doi.org/10.2337/dc22-0294.